Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Companion Animal Arthritis Market
Companion Animal Arthritis Market size was valued at approximately USD 3.4 billion and is projected to grow at a CAGR of 7.2% from 2024 and 2032. Arthritis, a common ailment in companion animals like dogs and cats, involves inflammation and degradation of joint cartilage and the underlying bone. This condition results in pain, stiffness, and reduced mobility, severely affecting the quality of life for these pets. The rising incidence of arthritis in companion animals, especially in dogs and cats, mirrors broader trends in pet ownership, an aging demographic, and evolving lifestyle factors.
One of the primary drivers for the growth of the companion animal arthritis market is the increasing ownership of pets. This surge in pet ownership has led to a heightened demand for companion animal healthcare products, including medications and supplements. According to the National Pet Owners Survey by the American Pet Products Association, approximately 86.9 million American families, or 66%, own pets ranging from birds and cats to dogs and ferrets. Furthermore, the global increase in pet adoption, combined with technological advancements in veterinary medicine—such as enhanced diagnostic tools and more effective treatment options—bolsters market growth. These innovations not only enhance treatment efficacy but also broaden the spectrum of treatable conditions.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Companion Animal Arthritis Market Size in 2023: | USD 3.4 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 7.2% |
2032 Value Projection: | USD 6.3 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 196 |
Tables, Charts & Figures: | 343 |
Segments covered: | Treatment Type, Disease Type, Animal Type, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|